RHEUMATOLOGY

Anti-Sp4 and Anti-CCAR1 autoantibodies in UK vs. US patients with adult and juvenile-onset anti-TIF1ƴ-positive myositis
McMorrow FK, Wedderburn LR, Chinoy H, Oldroyd A, Lamb JA, Rider LG, Mammen AL, Casciola-Rosen L, McHugh NJ and Tansley SL
Anti-TIF1γ autoantibodies are associated with malignancy in adult-onset idiopathic inflammatory myopathy (IIM) and this risk is attenuated if patients are also positive for anti-specificity protein 4 (Sp4) or anti-cell division cycle apoptosis regulator protein 1 (CCAR1). In anti-TIF1γ positive US dermatomyositis (DM) patients, anti-Sp4 and anti-CCAR1 autoantibody frequencies are reported as 32% and 43% in adults and 9% and 19% in juveniles, respectively. This study aims to identify the frequency of anti-Sp4 and anti-CCAR1 in adult and juvenile UK anti-TIF1ƴ-positive myositis populations and report clinical associations.
Comment on: Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case-control study
Lai SW, Hwang BF, Liu CS and Liao KF
Comment on: Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case-control study: Reply
Kim HW, Chang TI and Han SH
Comment on: Comparing clinical features between males and females with VEXAS syndrome: Data from literature analysis of patient reports: Reply
Lacombe V, Echerbault R, Bourguiba R and Georgin-Lavialle S
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Klein J, Wheeler A, Baker JF, Yang Y, Roul P, Frideres H, Wysham KD, Kerr GS, Reimold A, Ascherman DP, Kunkel GA, Cannon GW, Monach PA, Poole JA, Thiele GM, Mikuls TR and England BR
Investigate the association between the MUC5B rs35705950 promoter variant and survival in RA-associated interstitial lung disease (RA-ILD).
A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomised controlled AEGORA trial
Doumen M, De Meyst E, Bertrand D, Pazmino S, Piessens M, Joly J, Devinck M, Westhovens R and Verschueren P
We aimed to study if smartphone applications could support the self-management of RA, while investigating engagement and potential negative psychological effects with app-use.
Comment on: Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic reply
Cowley S, Harkins P, Kirby C, Molloy D, Conway R and Kane D
An Artificial Intelligence-Based Gout Management System Reduced Chronic Kidney Disease Incident and Improved Target Serum Urate Achievement
Qi H, Lu J, Dalbeth N, Sun M, Liu Z, Ji X, Ji A, Wang C, Sun W, Li X, He Y, Cui L, Han L, Chen Y, Yan F, Zhang Y, Terkeltaub R and Li C
Stage ≥ 3 chronic kidney disease (CKD) affects ∼25% of people with gout. The effects of urate-lowering therapy (ULT) on CKD incidence and progression have remained inconclusive. Here, we assessed the impact of a gout urate-lowering therapy (ULT) clinic intervention using artificial intelligence (AI) on CKD incidence and achievement of serum urate target.
Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 with disease activity and treatment response
Kamperman RG, Veldkamp SR, Evers SW, Lim J, van Schaik I, van Royen-Kerkhof A, van Wijk F, van der Kooi AJ, Jansen M and Raaphorst J
Novel biomarkers are needed to guide therapy in idiopathic inflammatory myopathies (IIM). Expression of Siglec-1, a type I interferon biomarker, was examined in adult patients with IIM in relation to disease activity and treatment response.
Comment on: "Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic"
Donskov AO, Våben CS, Nielsen EL, Nielsen AW, Hauge EM and Keller KK
Anti-PTX3 antibodies: towards a new concept of pain in rheumatoid arthritis?
Duarte C and Inês LS
Enhancing Gout Diagnosis with Deep Learning in Dual-energy Computed Tomography: A Retrospective Analysis of Crystal and Artifact Differentiation
Choi Y, Castro-Zunti R, Lee D, Yun JS, Choi Y, Ko SB, Choi EJ, Jin GY, Yoo WH and Park EH
To evaluate whether the application of deep learning (DL) could achieve high diagnostic accuracy in differentiating between green colour coding, indicative of tophi, and clumpy artifacts observed in dual-energy computed tomography (DECT) scans.
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Nguyen Y, Baron G, Hamamouche N, Belkhir R, Miconnet S, Soubrier M, Hostachy C, Thevenot P, Basch A, Truchetet ME, Claudepierre P, Dernis E, Marotte H, Flipo RM, Brocq O, Morel J, Fautrel B, Salliot C, Saraux A, Leske C, Schaeverbeke T, Ravaud P, Mariette X, Ruyssen-Witrand A, Seror R and
To evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among rheumatoid arthritis (RA) patients treated with anti-TNF therapies, and to identify factors associated with vaccination.
Comment on: Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic. Reply
Cowley S, Harkins P, Kirby C, Molloy D, Conway R and Kane D
Cell-integrated serum-induced signalling patterns can differentiate between hand and knee osteoarthritis patients
Neefjes M, Housmans BAC, Kaffa C, Thielen NGM, Joosten LAB, van den Ende CHM, Vitters EL, van den Akker GGH, Welting TJM, van Caam APM and van der Kraan PM
OA is a very heterogeneous disease. Here, we aimed to differentiate OA patients based on their serum-induced cell-integrated signalling patterns.
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus
Carnazzo V, Gulli F, Basile V, Di Santo R, Niccolini B, Redi S, Vinante I, Napodano C, Pocino K, Rapaccini GL, Lizzio MM, Marino M, Ciasca G and Basile U
Systemic autoimmune rheumatic diseases (SARDs) are characterized by chronic inflammation. Reliable biomarkers are crucial for diagnosis, monitoring disease progression and therapeutic responses. This study explores serum Syndecan-1 (SDC-1) as a biomarker for these conditions and its relationship with free light chain (FLC) levels.
Association Between Antiphospholipid Antibodies and Diffuse Alveolar Hemorrhage Risk in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
González-Treviño M, Figueroa-Parra G, Yang JX, Prokop LJ, Gamal SM, García MA, James JA, Knight JS, Murad MH, Narvaez J, Pons-Estel BA, Quintana RM, Specks U, Yang X and Duarte-García A
To assess the association of antiphospholipid antibodies (aPL) and diffuse alveolar hemorrhage (DAH) in patients with systemic lupus erythematosus (SLE) by performing a systematic review and meta-analysis.
Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis
Snoeck Henkemans SVJ, Vis M, Koc GH, Luime JJ, Kok MR, Tchetverikov I, van der Kooij SM, Bijsterbosch J, van der Helm-van Mil AHM and de Jong PHP
To investigate the association between depression and anxiety and the inability to achieve remission in rheumatoid arthritis(RA) and psoriatic arthritis(PsA) patients. In addition, the association between depressive and anxiety symptoms and disease activity components were explored.
Clinical course of pediatric-onset Behçet's Disease in young adulthood
Bozkurt T, Yıldız M, Deniz R, Yazıcı A, Karabacak M, Karataş H, Kutluğ-Ağaçkıran S, Günalp A, Kılıç Könte E, Şahin S, Köker O, Barut K, Bes C, Cefle A, Ergun T, Direskeneli H, Kasapçopur Ö and Alibaz-Oner F
Although Behçet's disease (BD) typically manifests in the second or third decade of life, initial symptoms may appear at a younger age. It may also take a longer time for the full disease phenotype to develop after the first symptom onset in pediatric patients. In this study we aimed to assess the clinical course of pediatric-onset BD in adulthood period.
Comment on: Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic
Manzo C
68Ga-FAPI and 18F-NaF PET/CT in psoriatic arthritis: a comparative study
Yang F, Lu C, Pan Q, Zhang R, Yang M, Wang Q, Li M, Zeng X, Luo Y and Leng X
As fibroblast-like synoviocyte activation and bone formation are associated with psoriatic arthritis (PsA), positron emission tomography (PET) using the tracers of 68Ga-fibroblast activation protein inhibitor (FAPI) and 18F-sodium fluoride (NaF) may sensitively detect the disease. In this prospective study, we aimed to evaluate the performance of 68Ga-FAPI PET/CT in PsA and to compare it with 18F-NaF PET/CT.